PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Fig extract prevented decline in muscle weight and nerve conduction velocity, mitigated motor function impairment, myelin thinning, and axon diameter reduction, and enhanced macrophage infiltration [PMID:38942739]
Fig leaf tea suppressed degranulation in RBL-2H3 cells and inhibited allergic dermatitis in mice [PMID:31987005]
Reviews indicate potential roles against cancer, diabetes, and inflammation due to high phytochemical content [PMID:36770628, PMID:36288779]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38820103 (2024) — Botanical Briefs: Fig Phytophotodermatitis (Ficus carica). · Cutis
- 2.PMID: 36770628 (2023) — Industrial Application and Health Prospective of Fig (Ficus carica) By-Products. · Molecules (Basel, Switzerland)
- 3.PMID: 24940252 (2014) — 1-Cyclo-hexyl-6,7-dimeth-oxy-1,4-di-hydro-naphthalene. · Acta crystallographica. Section E, Structure reports online
- 4.PMID: 34094890 (2020) — Ficus carica assisted green synthesis of metal nanoparticles: A mini review. · Biotechnology reports (Amsterdam, Netherlands)
- 5.PMID: 35656183 (2022) — Inhibitory effects of Ficus carica and Olea europaea on pro-inflammatory cytokines: A review.